Skip to main content
Advertisement
Advertisement

TLPH

TLPH logo

Talphera, Inc. Common Stock

1.17
USD
Sponsored
+0.01
+0.86%
Sep 24, 15:58 UTC -4
Closed
exchange

After-Market

1.17

0.00
-0.43%

Talphera, Inc. Common Stock Profile

About

Talphera Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate consists Niyad(TM). Talphera Inc., formerly known as AcelRx Pharmaceuticals Inc., is based in SAN MATEO, Calif.

Info & Links

CEO

Vincent J. Angotti

Headquarters

1850 Gateway Drive, Suite 175
San Mateo, CA 94404, UNITED STATES

Sector

Medical

Auditor

BPM LLP

Share holders

45

Employees

12

Talphera, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

60.47M

Enterprise Value

59.73M

Enterprise Value/EBITDA(ttm)

-3.95

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.22

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-87.28%

Return on Invested Capital(ttm)

-89.04%

Return on Assets(ttm)

-51.36%

Income Statement

Revenue(ttm)

1000.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

1000.00

EBITDA(ttm)3

-15.11M

Net Income Available to Common(ttm)

-15.08M

Diluted EPS(ttm)

-0.27

Share Statistics

Beta (5Y Monthly)

0.69

52-Week Change

26.42%

S&P 500 52-Week Change

19.38%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

51.91M

Dividend Yield

0.00%

Float4

50.09M

% Held by Insiders

3.50%

% Held by Institutions

37.67%

Balance Sheet

Total Cash(mrq)

17.08M

Total Cash Per Share(mrq)

0.33

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.29%

Quick Ratio(mrq)

4.29%

Book Value Per Share(mrq)

0.28

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.10

Free Cash Flow(ytd)

-7.32M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement